Comparison of Efficacy and Safety between Carboplatin-Etoposide and Cisplatin-Etoposide Combination Therapy in Patients with Advanced Neuroendocrine Carcinoma: A Retrospective Study
Hiroo Imai(Tohoku University), Chikashi Ishioka(Tohoku University), Keigo Komine(Tohoku University), Ken Saijo(Tohoku University), Masanobu Takahashi(Shibaura Institute of Technology), Noriko Takenaga(Tohoku University Hospital), Yoshifumi Kawamura(Tohoku University), Hidekazu Shirota(Tohoku University), Kota Ouchi(Tohoku University), Yuki Kasahara(Tohoku University), Shuto Kodera(Tohoku University), Tomoyuki Iwasaki(Tohoku University)
Cited by 4
Related Papers
Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
|Nature|2011|388
MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
|The EMBO Journal|2014|302
Human protein factory for converting the transcriptome into an in vitro–expressed proteome
|Nature Methods|2008|269
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
|Molecular Cancer Therapeutics|2006|243
Differential Contributions of<i>BRCA1</i>and<i>BRCA2</i>to Early-Onset Breast Cancer
|New England Journal of Medicine|1997|211